EPO Patents = 1

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Paul Joseph Mark Jackson (5 out of 5 patents)

David Edwin Thurston (5 out of 21 patents)

Khondaker Mirazur Rahman (5 out of 9 patents)

5 patents: Sort by Forward Citations

1. 11466032 - Cytotoxic agents (2022-10-11),

2. 10975074 - Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines (2021-04-13),

3. 10975072 - Substituted 6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepines as anti-proliferative agents (2021-04-13),

4. 10399970 - Pyrridinobenzodiazepine and benzopyrridodiazecine compounds (2019-09-03),

5. 9999625 - Pyrrolobenzodiazepine compounds (2018-06-19),

Femtogenix is a biotechnology company focused on developing novel DNA-interactive payloads for targeted cancer therapies. The company's proprietary payload platform enables the precise delivery of highly potent drugs to cancer cells, while minimizing off-target effects. Femtogenix's innovative approach holds great promise for improving the effectiveness and safety of cancer treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#503 in

#3,139 in

London, United Kingdom

Femtogenix Limited

Forward Citations = 1

3 inventors:

Paul Joseph Mark Jackson (5 out of 5 patents)

David Edwin Thurston (5 out of 21 patents)

Khondaker Mirazur Rahman (5 out of 9 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com